Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Immunotherapy + Targeted Therapy for Lung Cancer
Recruiting1 awardPhase 1 & 2
Boston, Massachusetts
This trial is testing a combination of therapies, one of which is a PD-1 antagonist monoclonal antibody. The first part of the trial (Phase 1b) is testing the safety of the combination, and the second part (Phase 2) will test how well the combination works against cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.